On-Demand Pearce IP Webinars
Listen to world-leading pharma/biopharma patent lawyers across three different time zones on a 70-minute webinar addressing recent developments in Patent Term Extensions (PTE), Patent Term Adjustments (PTA), and Supplementary Protection Certificates (SPC). This webinar took place January 26, 2023 offering perspectives from the United States, the United Kingdom, Europe, and Australia. This seminar addresses recent patent law developments, including:
- EU & UK – Combination products: more questions of interpretation for the Court of Justice of the European Union to consider; SPC Manufacturing Waivers: when might pharma companies elect to seek a waiver under the new EU & UK regulations?
- US – PTA/PTE: Obviousness-type double patenting (ODP) and patent term; when might a terminal disclaimer cut short a PTA (in addition to a PTE)?
- AU – Why is PTE the hot topic in AU patent law? Is there any limit to the number and types of patents that can be extended in AU? Can I use a competitor product to obtain PTE
Who is this webinar for?
If you are a pharmaceutical/biopharmaceutical company operating globally and interested in understanding the regional nuances of PTE/PTA/SPC, this webinar is not to be missed.
Speakers
- Naomi Pearce, CEO, Executive Lawyer, Patent Attorney and TM Attorney, Pearce IP, Australia
- Ann Henry, Partner, IP and Data Litigation, Pinsent Masons, Ireland
- Charlotte Weekes, Partner, IP, Pinsent Masons, UK
- Gaby Longsworth, Director, Biotechnology and Chemical Group, Sterne Kessler, US
Downloads
- PDF Download of the Webinar Slides
Enter your email below to access our webinars
Loading… Stream